Literature DB >> 25869556

Advances in the analytical methodologies: Profiling steroids in familiar pathways-challenging dogmas.

Liezl M Bloem1, Karl-Heinz Storbeck1, Pieter Swart1, Therina du Toit1, Lindie Schloms1, Amanda C Swart2.   

Abstract

The comprehensive evaluation of the adrenal steroidogenic pathway, given its complexity, requires methodology beyond the standard techniques currently employed. Advances in LC-MS/MS, coupled with in vitro cell models that produce all the steroid metabolites of the mineralo-, glucocorticoid and androgen arms, present a powerful approach for the comprehensive evaluation of adrenal steroidogenesis in response to compounds of interest including bioactives, drug treatments and endocrine disrupting compounds. UHPLC-MS/MS analysis of steroid panels in forskolin, angiotensin II and K(+) stimulated H295R cells provides a snapshot of their effect on intermediates and end products of adrenal steroidogenesis. The impact of full steroid panel evaluations by LC- and GC-MS/MS extends to clinical profiling with the characterization of normal pediatric steroid reference ranges in sexual development and of disease-specific profiles improving diagnosis and sub classification. Comprehensive analyses of steroid profiles may potentially improve patient outcomes together with the application of treatments specifically suited to clinical subgroups. LC-MS/MS and GC-MS/MS applications in the analyses of comprehensive steroid panels are demonstrated in clinical conditions such as congenital adrenal hyperplasia in newborns requiring accurate diagnoses and in predicting metabolic risk in polycystic ovary syndrome patients. Most notable perhaps is the impact of LC-MS/MS evaluations on our understanding of the basic biochemistry of steroidogenesis with the detection of the long forgotten adrenal steroid, 11β-hydroxyandrostenedione, at significant levels. The characterization of its metabolism to androgen receptor ligands in the LNCaP prostate cancel cell model, specifically within the context of recurring prostate cancer, lends new perspectives to old dogmas. We demonstrate that UHPLC-MS/MS has enabled the analyses of novel metabolites of the enzymes, SRD5A, 11βHSD and 17βHSD, in LNCaP cells. Undoubtedly, the continuous advances in the analytical methodologies used for steroid profiling and quantification will give impetus to the unraveling of the remaining enigmas, old and new, of both hormone biosynthesis and metabolism.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  11βHSD; H295R adrenal cell model; HPLC–mass spectrometry; LNCaP prostate cancer cell model; PCOS; UPC²–MS/MS steroid analyses

Mesh:

Substances:

Year:  2015        PMID: 25869556     DOI: 10.1016/j.jsbmb.2015.04.009

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  11 in total

1.  Adrenal androgens rescue prostatic dihydrotestosterone production and growth of prostate cancer cells after castration.

Authors:  Yue Wu; Li Tang; Gissou Azabdaftari; Elena Pop; Gary J Smith
Journal:  Mol Cell Endocrinol       Date:  2019-02-23       Impact factor: 4.102

2.  Bacterial steroid-17,20-desmolase is a taxonomically rare enzymatic pathway that converts prednisone to 1,4-androstanediene-3,11,17-trione, a metabolite that causes proliferation of prostate cancer cells.

Authors:  Lindsey K Ly; Joe L Rowles; Hans Müller Paul; João M P Alves; Camdon Yemm; Patricia M Wolf; Saravanan Devendran; Matthew E Hudson; David J Morris; John W Erdman; Jason M Ridlon
Journal:  J Steroid Biochem Mol Biol       Date:  2019-12-20       Impact factor: 4.292

3.  Clinical significance of 11-oxygenated androgens.

Authors:  Adina F Turcu; Richard J Auchus
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-06       Impact factor: 3.243

4.  Current models of care for disorders of sex development - results from an International survey of specialist centres.

Authors:  Andreas Kyriakou; Arianne Dessens; Jillian Bryce; Violeta Iotova; Anders Juul; Maciej Krawczynski; Agneta Nordenskjöld; Marta Rozas; Caroline Sanders; Olaf Hiort; S Faisal Ahmed
Journal:  Orphanet J Rare Dis       Date:  2016-11-21       Impact factor: 4.123

Review 5.  Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology.

Authors:  Roshan Dadachanji; Nuzhat Shaikh; Srabani Mukherjee
Journal:  Genet Res Int       Date:  2018-02-18

6.  Determination of dehydroepiandrosterone and its biologically active oxygenated metabolites in human plasma evinces a hormonal imbalance during HIV-TB coinfection.

Authors:  María Belén Vecchione; Javier Eiras; Guadalupe Verónica Suarez; Matías Tomás Angerami; Cecilia Marquez; Omar Sued; Graciela Ben; Héctor Miguel Pérez; Diego Gonzalez; Patricia Maidana; Viviana Mesch; María Florencia Quiroga; Andrea Claudia Bruttomesso
Journal:  Sci Rep       Date:  2018-04-27       Impact factor: 4.379

Review 7.  GC/MS in Recent Years Has Defined the Normal and Clinically Disordered Steroidome: Will It Soon Be Surpassed by LC/Tandem MS in This Role?

Authors:  Cedric Shackleton; Oscar J Pozo; Josep Marcos
Journal:  J Endocr Soc       Date:  2018-07-09

8.  Reliability of a dried urine test for comprehensive assessment of urine hormones and metabolites.

Authors:  Mark Newman; Desmond A Curran
Journal:  BMC Chem       Date:  2021-03-15

Review 9.  MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease.

Authors:  Lina Schiffer; Punith Kempegowda; Wiebke Arlt; Michael W O'Reilly
Journal:  Eur J Endocrinol       Date:  2017-05-31       Impact factor: 6.664

Review 10.  Intracrine androgen biosynthesis, metabolism and action revisited.

Authors:  Lina Schiffer; Wiebke Arlt; Karl-Heinz Storbeck
Journal:  Mol Cell Endocrinol       Date:  2017-09-01       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.